InvestorWire NewsRoom

Article

ROTH Announces Biotech / Medtech Details for Virtual 33rd Annual Roth Conference
March 15, 2021

ROTH Announces Biotech / Medtech Details for Virtual 33rd Annual Roth Conference

ROTH is hosting its 33rd Annual Roth Conference virtually this year, from March 15-17. Featured at the event under the Pharmaceuticals/Medical technology umbrella will be 1-on-1/small group meetings for institutional investors, an industry panel and numerous virtual fireside chats.

Details on the Panel:

Flipping the Switch to Profitability Panel – March 16 at 10:00 AM

Description: This panel will highlight three companies in ROTH’s Medical Technologies coverage universe (IRIX, SRTS, CSBR) that are approaching or becoming cash flow positive. ROTH is holding this panel as a forum where investors can get to know these three companies better.

Panelists:

  • Iridex Corporation (IRIX) David Bruce, CEO
  • Sensus Healthcare Inc (SRTS) Joe Sardano, CEO
  • Champions Oncology, Inc (CSBR) David Miller, CFO

Fireside Chats:

Monday, March 15

  • 11:30 – 11:55 AM – Ligand Pharmaceuticals, Inc (LGND)
  • 4:30 – 4:55 PM – InMed Pharmaceuticals Inc (INM)
  • 5:00 – 5:25 PM – Assertio Therapeutics, Inc (ASRT)

Tuesday, March 17

  • 11:00 – 11:25 AM – Fortress Biotech, Inc (FBIO)
  • 11:30 – 11:55 AM – Vivos Therapeutics, Inc (VVOS)

ROTH also has 1×1 meetings available with the following companies under its coverage:

  • Assertio Therapeutics, Inc (ASRT)
  • Beyond Air, Inc (XAIR)
  • BioDelivery Sciences International, Inc. (BDSI)
  • Catalyst Pharmaceuticals, Inc (CPRX)
  • Champions Oncology, Inc (CSBR)
  • Delcath Systems, Inc (DCTH)
  • Fortress Biotech, Inc (FBIO)
  • InMed Pharmaceuticals Inc (INM)
  • Intec Pharma Ltd (NTEC)
  • INVO Bioscience, Inc (INVO)
  • IRadimed Corporation (IRMD)
  • Iridex Corporation (IRIX)
  • Lannett Company (LCI)
  • LeMaitre Vascular (LMAT)
  • Ligand Pharmaceuticals Inc (LGND)
  • Myomo, Inc (MYO)
  • RedHill Biopharma Ltd (RDHL)
  • Sensus Healthcare, Inc (SRTS)
  • Soliton, Inc (SOLY)
  • Viking Therapeutics, Inc (VKTX)
  • Vivos Therapeutics, Inc (VVOS)
  • Zynerba Pharmaceuticals, Inc (ZYNE)

For more information on this year’s event, visit https://ibn.fm/nkr8O

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Recent Articles

Release Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).